Abiopharma

🔍 Sirard Cynthia (Executive)

Company: Compass Therapeutics, Inc. (CMPX)

Report Date: 2026-01-02

Detailed Transactions and Holdings:

• Acquired 1,000,000 shares of STOCK OPTION (RIGHT TO BUY) at $5.17 per share (Derivative)
  Date: 2026-01-02 | Code: A | Expires: 2036-01-02 | equity_swap_involved: 0 | shares_owned_after: 1,000,000.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: The options were granted pursuant to the Compass Therapeutics, Inc. 2025 Inducement Plan as a material inducement to the Reporting Person's acceptance of employment with the Issuer in accordance with Nasdaq Rule 5635(c)(4).
• F2: The options will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on January 2, 2027, with the remaining 75% vesting in 36 substantially equal monthly installments thereafter.